Matsuoka S, Fujii H, Iihara H, Ohata K, et al. Emetogenicity and Risk Factors of Nausea and Vomiting in Patients With Metastatic Colorectal Cancer Receiving Trifluridine/Tipiracil and Bevacizumab Chemotherapy. Anticancer Res 2023;43:2351-2357.
PMID: 37097664